Consensus Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. 04:35:07 28/08/2026 pm IST			5-day change	1st Jan Change
1,423.50 ^INR	+0.25%		-0.61%	-5.81%

25/08	Cipla's Pithampur, India Unit Gets 7 Observations From US FDA	MT
14/08	Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology	CI

Evolution of the Average Target: Cipla Limited

Evolution of the Target Price: Cipla Limited

Changes in Analyst Recommendations: Cipla Limited

78480d0f21b0ac6ce21.UlVM1SkfSpCxY8Ow3mbWqkIaKI62dprOwvOzVdYXRz0.MTg9vU9RMPjmLKvD6j-42xV9berkPdWXup_KOYwiPw8YYHTkSGZ5wf4bhg~b03c9542a411970f49c0dbb9b125230f

Analysts' recommendations: Cipla Limited

24/07	Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform	MT
24/06	Avendus Spark Upgrades Cipla to Buy from Add; Price Target is INR1,710	MT
14/05	Elara Securities Downgrades Cipla to Reduce from Accumulate; Price Target is INR1,349	MT
14/05	Elara Securities Downgrades Cipla to Sell from Neutral; Price Target is INR1,180	MT
14/05	JM Financial Upgrades Cipla to Buy from Add; Price Target is INR1,546	MT
14/05	Emkay Global Upgrades Cipla to Add from Reduce; Price Target is INR1,450	MT
14/05	Avendus Spark Upgrades Cipla to Add from Reduce; Price Target is INR1,455	MT
14/05	Nirmal Bang Downgrades Cipla to Hold from Buy; Price Target is INR1,404	MT
08/05	Jefferies Adjusts Cipla's Price Target to INR1,120 From INR1,170, Keeps at Underperform	MT
24/04	ICICI Securities Upgrades Cipla to Buy from Add; Price Target is INR1,550	MT
27/01	Nomura Adjusts Cipla's Price Target to INR1,510 From INR1,770, Keeps at Buy	MT
26/01	Jefferies Downgrades Cipla to Underperform From Hold, Adjusts Price Target to INR1,170 From INR1,630	MT
03/11	Nomura Adjusts Cipla's Price Target to INR1,770 From INR1,810, Keeps at Buy	MT
31/25/31	Choice Equity Downgrades Cipla to Add from Buy; Price Target is INR1,700	MT
31/25/31	Choice Equity Downgrades Cipla to Reduce from Add, Price Target is INR1,580	MT
31/25/31	Phillip Securities Upgrades Cipla to Neutral from Sell; Price Target is INR1,420	MT
31/25/31	Prabhudas Lilladher Downgrades Cipla to Accumulate from Buy, Price Target is INR1,675	MT
31/25/31	JM Financial Downgrades Cipla to Reduce from Hold; Price Target is INR1,600	MT
29/25/29	Nomura Adjusts Cipla's Price Target to INR1,810 From INR1,780, Keeps at Buy	MT
14/25/14	Jefferies Adjusts Cipla's Price Target to INR1,610 From INR1,580, Keeps at Hold	MT
31/25/31	Nomura Adjusts Cipla's Price Target to INR1,780 From INR1,800, Keeps at Buy	MT
29/25/29	Jefferies Adjusts Cipla's Price Target to INR1,580 From INR1,560, Keeps at Hold	MT
05/24/05	Nomura Upgrades Cipla to Buy From Neutral, Adjusts Price Target to INR1,800 From INR1,568	MT
30/24/30	Jefferies Adjusts Cipla's Price Target to INR1,480 From INR1,450, Keeps at Hold	MT
29/24/29	Jefferies Adjusts Cipla's Price Target to INR1,450 From INR1,400, Keeps at Hold	MT

More recommendations

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CIPLA LIMITED			+6.01%
SUN PHARMACEUTICAL INDUSTRIES LTD.			+12.88%
OTSUKA HOLDINGS CO., LTD.			+15.04%
ZYDUS LIFESCIENCES LIMITED			+0.4%
KRKA, D. D.			-7.65%
GEDEON RICHTER			-3.09%
GLENMARK PHARMACEUTICALS LIMITED			-0.69%
ONO PHARMACEUTICAL CO., LTD.			+2.09%
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-	-	-
AJANTA PHARMA LIMITED			+5.74%
Average			+3.41%
Weighted average by Cap.			+8.32%